Drug Interactions & Safety at AACAP Annual Meeting 2026
27 sessions on drug interactions & safety · October 26–31, 2026, Atlanta, GA. Compare drug interactions & safety at other meetings →
Monday, October 26
13:30–15:30 · Session · Clinical Perspectives
Medication Maze: Navigating Comorbidities and Maladaptive Behaviors in ASD
Alice R. Mao · Olivia Hindera · Bryan H. King · Roma Vasa
Clinical perspectives session on medication approaches for children and adolescents with autism who have comorbid conditions and maladaptive behaviors.
15:30–17:30 · Lecture · Clinical Perspectives
Focus on Clinically Relevant Pharmacokinetic and Pharmacodynamic Genes
Reviews the pharmacokinetic and pharmacodynamic genes most relevant to prescribing psychotropic medications for children and adolescents.
Child & Adolescent · Pharmacogenomics & Precision Psychiatry
Tuesday, October 27
14:00–16:00 · Session · Clinical Perspectives
Practical Framework for Assessing and Managing Clinically Significant Psychotropic Medication Side Effects in Children and Adolescents
Salma Malik · Raman Baweja · Jeffrey Robert Strawn · Sadiq Naveed · Conor Wilson
Offers a practical approach to recognizing and managing clinically significant side effects of psychotropic medications in youth.
14:00–16:00 · Lecture · Clinical Perspectives
Neurological Side Effects of Psychotropic Medications in Children and Adolescents: Recognition, Management, and Clinical Implications
Covers recognizing and managing neurological adverse effects of psychotropics in young patients.
Child & Adolescent · Tardive Dyskinesia & Movement Disorders
14:00–16:00 · Lecture · Clinical Perspectives
Systematic Framework for Anticipating, Identifying, Assessing, and Managing Medication-Related Adverse Effects
Presents a structured framework for anticipating and managing adverse effects of psychotropic medications in youth.
Wednesday, October 28
15:00–17:00 · Lecture · Clinical Perspectives
The Risks Beneath the Hype: GLP-1 Use and Eating Disorders
Examines the risks associated with GLP-1 medication use in the context of eating disorders.
Posters (6)
- Psychosis as an Adverse Effect of Antibiotics in Children and Adolescents — Brian Miller et al.
- Pharmacovigilance Analysis of Psychiatric Adverse Events Associated With Semaglutide and Liraglutide — Qiyang Pan et al.
- The Early Prolactin Signal: Hormonal Impact of Second-Generation Antipsychotics in Hospitalized Children — Pari Desai et al.
- Psychopharmacological Management of Inappropriate Sexual Behaviors in Adolescents With ASD and/or Intellectual Disabilities: Systematic Review and Ethical Analysis — Sofia Andreevna Quiroza et al.
- Sexual Side Effects Associated With Child and Adolescent SSRI Use: A Systematic Review — Jonathan S. Shaw et al.
- Medication-Induced Emotional Blunting in Adolescents: A Neglected Dimension of Psychopharmacology—A Scoping Review — Marcos Rocha et al.
Thursday, October 29
14:30–16:00 · Lecture
Safety, Monitoring, and Controversies in Long-Term Stimulant Use
Covers safety, monitoring and debated issues in long-term stimulant use.
Posters (6)
- Improving Timely Lab Monitoring for Metabolic Syndrome in Children With ASD — Sharmin Kamrun et al.
- Missed Opportunities: Metabolic Monitoring in Hospitalized Youth With ASD Receiving Atypical Antipsychotics — Zara Kanwal et al.
- The Importance of Metabolic Monitoring in Medication Management of Behaviors in Autistic Youth — Amber Green et al.
- Neuroleptic Malignant Syndrome in Pediatric Patients: Patterns of Vulnerability and Prescribing Risk — Gurkirat Kaur Bhangu et al.
- Beyond AI Psychosis and Sycophancy: Structural Drift as a System-Level Safety Failure — Jasmine E. Kim et al.
- Scoping Review of Side Effects of ECT in Youth — Lindsay M. Oberman et al.
Friday, October 30
09:00–11:00 · Lecture
Postpartum Depression and the Emerging Mother–Infant Relationship: Associations with SSRI Medication Use
Examines how postpartum depression and SSRI use relate to the developing mother-infant relationship.
Posters (1)
- Surveying Common Medications and ADHD Symptoms: Potential Mimics — Douglas A. Russell et al.
Saturday, October 31
09:00–11:00 · Lecture · Clinical Perspectives
Web-Based Review Process for Psychotropic Prescribing: Challenges and Approaches
Jody L. Brown · Andres J. Pumariega
Examines the challenges and approaches of running a web-based review process for psychotropic prescribing in child welfare.
09:00–11:00 · Lecture · Clinical Perspectives
Psychotropic Review Database for 15 Years’ Experience: Findings, Trends, and Possible Future Directions
Takahiro Soda · Aman Pathak · Andres J. Pumariega · Yonghui Wu
Presents findings, trends and future directions from a 15-year database of psychotropic prescribing reviews for youth in child welfare.
09:00–11:00 · Lecture · Clinical Perspectives
Review Process for Psychotropic Prescribing: Challenging Case Scenarios
Walks through difficult case scenarios encountered in the psychotropic prescribing review process for children in child welfare.
10:00–12:00 · Lecture
Psychopharmacological Aspects of Psycho-Oncology
Reviews medication considerations for psychiatric care of children with cancer.
12:30–14:30 · Lecture
Using Pharmacology to Balance Harm Reduction With Clinical Opportunity From Major and Minor Cannabinoids
Discusses cannabinoid pharmacology to weigh harm reduction against clinical potential of major and minor cannabinoids.
Posters (1)
- Neuropsychological and Psychiatric Outcomes During Isotretinoin Treatment in Adolescents With Acne Vulgaris — Hansa Betül Öz Genişoğlu et al.
Other topics at this meeting
Child & Adolescent 1361Autism & Neurodevelopmental Disorders 272Diverse & Underserved Populations 231Practice, Policy & Workforce 171Psychotherapy 166Education & Training 156Digital Psychiatry & AI 149Measurement-Based Care & Diagnosis 145ADHD 135Neuroscience & Mechanisms 124PTSD & Trauma 114Suicide & Self-Harm 110